|
HS Code |
420611 |
| Product Name | 2-Nitro-3-Fluoro-4-Bromoaniline |
| Molecular Formula | C6H4BrFN2O2 |
| Molecular Weight | 251.01 g/mol |
| Cas Number | 866102-67-6 |
| Appearance | Yellow to brown solid |
| Melting Point | 98-102°C |
| Solubility | Slightly soluble in polar organic solvents |
| Purity | >97% |
| Chemical Class | Aniline derivative |
| Smiles | Nc1c(Br)cc(F)c([N+](=O)[O-])c1 |
| Inchi | InChI=1S/C6H4BrFN2O2/c7-3-1-4(8)5(10-2-3)6(9)11/h1-2H,10H2 |
As an accredited 2-Nitro-3-Fluoro-4-Bromoaniline factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 2-Nitro-3-Fluoro-4-Bromoaniline prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Walking through the loud halls of any organic synthesis lab or the orderly aisles of a pharmaceutical company, I’ve caught glimpses of a little bottle labeled “2-Nitro-3-Fluoro-4-Bromoaniline.” It’s a name that grabs your attention—not just because it rolls awkwardly off the tongue, but because it signals something more than a routine intermediate. Over the years, I’ve seen it quietly help drive innovation, especially in spaces where precision and reliability matter most. In my experiences, connecting the dots between pure chemicals and real-life applications requires more than a datasheet; it demands some honest talk about what a compound offers and where its real value comes through.
2-Nitro-3-Fluoro-4-Bromoaniline stands out by bringing together three distinct functional groups on one compact aromatic ring. Organic chemists know that fluorine, bromine, and nitro groups rarely play this nicely together in one molecule, at least not without a lot of intention behind the synthesis. The structure isn’t just for show. Each part serves a role: The nitro group pulls electrons and changes reactivity patterns, the fluorine atom adds a subtle twist in both reactivity and physical properties, and the bromine brings its own set of possibilities for transformation. I remember troubleshooting bench reactions with less feature-rich anilines—they just didn’t match up on versatility.
Many chemicals claim they can take on a whole range of uses, but few back that up with both stability and adaptability. This compound has a way of making itself just reactive enough for transformations while holding together in storage. Combine this with bench-tested purity and you start to appreciate its place as a trusted ingredient for advanced chemistry. From years working in R&D, watching others and doing it myself, I’ve seen how difficult it can be to find reliable starting points, especially for targeted modifications of aromatic systems. A molecule like this feels like a relief in that sense—less second-guessing, fewer surprises in scale-up, and actual confidence when moving towards more complex syntheses.
I want to separate the noise from real-life utility. This is not just a plaything for academic exercises. The unique blend of functional groups brings practical benefits for pharmaceutical research, crop science, and specialty materials. I've witnessed how this core skeleton gets picked up in the quest for new anti-infectives, with the electron-drawing nitro group opening up new binding modes, and the fluoro substituent tweaking metabolic stability. The brominated position invites Suzuki or other cross-coupling tricks for expanding chemical diversity. These are not hypothetical benefits – patent filings and the scientific literature keep pointing back to molecular scaffolds that begin just like this.
The world of halogenated anilines is packed with similar-sounding options, but not all bring the same breadth or reliability. Some cousins in this chemical family might lack the fluoro substituent, which I’ve found essential for dialing in target interactions in drug design. The absence of bromine can rule out efficient couplings in later stages of synthesis. I’ve seen teams struggle with less reactive analogues, spending precious hours pushing sluggish reactions or battling impurities that don’t want to leave. This one tends to stay consistent across batches—a quality that matters as projects scale from milligram runs on a workbench to kilogram preps in a pilot plant.
Purity profiles for 2-Nitro-3-Fluoro-4-Bromoaniline often hit the mark, showing little to no sign of troublesome isomers or over-bromination. There’s no hand-wringing about odd side-products cropping up later, which, in my view, sets the stage for smoother process development. The melting point, solubility features, and color fit the expectations for an intermediate living its life between raw materials and high-value end products.
Selecting your upstream intermediates can feel like picking a route on a cross-country road trip. Get it right, and you make steady progress. Get it wrong, and expect breakdowns, delays, and expensive detours. In my experience, 2-Nitro-3-Fluoro-4-Bromoaniline carves out a legitimate lane in the toolkit for assembling complicated targets without frequent troubleshooting. Its trifecta of functional groups keeps options open—whether the goal is turning it quickly into a new amine, swapping pieces through palladium-catalyzed couplings, or testing stability under tough conditions. A less equipped molecule just doesn’t open the same doors. I’ve watched ambitious medicinal chemistry projects stumble because they started with cheaper, less sophisticated building blocks, only to find out that later-stage modifications became nearly impossible without ripping up the whole synthetic plan.
For anyone mapping out a new synthesis, this compound stands as a flexible fork in the road. The three substituents don’t just mark positions on a ring; they change the whole reactivity grid. Nitro and fluoro groups steer selectivity, so unwanted byproducts are easier to avoid. The bromine balances that, enabling precise introduction of new fragments through cross-coupling. I’ve seen this balance pay off, leading to higher yields and cleaner reactions when time and budget pressures weigh heavy on a project.
In years of peer-reviewed studies, this compound and its siblings consistently sharpen the science. Publications in high-ranking chemistry journals, as well as biotech patent disclosures, highlight its recurring value—especially where step economy and selectivity are non-negotiable. Because this compound combines electron-withdrawing nitro and fluoro substituents, researchers get a jump in site-selective reactivity. With the right catalysis, cross-coupling on the bromo point leads to extended scaffolds needed in agrochemical or pharmaceutical pipelines. In one memorable project, our team leveraged this intermediate to quickly assemble a library of fluorinated anilines, all showing distinct biological profiles in kinase assays. Having this on our shelf let us skip several tiresome synthetic steps, saved time, and moved us quicker to publishable data.
There’s no substitute for hard-won, hands-on results; my colleagues and I have avoided headaches by sticking to 2-Nitro-3-Fluoro-4-Bromoaniline for certain challenging multi-step sequences. In a climate where every dollar counts and lab capacity is stretched thin, the few dollars more spent upfront pay dividends in process reliability. More importantly, the yields don’t just look good on paper—they hold up in the flask. I’ve seen parallel reactions with and without the fluoro group, and the differences in downstream reactivity and product profiles speak clearly. Experimental reproducibility across batches means it becomes a backbone, not a wildcard, in workflow planning.
For end users in pharma or fine chemicals, a compound like this doesn’t live in isolation. Its reach extends well past the lab notebook—it shapes the economics of drug discovery and the timelines for regulatory milestones. When our pilot team switched to 2-Nitro-3-Fluoro-4-Bromoaniline as a standard intermediate in synthesizing a niche class of bioactive molecules, we saw fewer delays and less rework. Regulatory reviewers look closely at the traceability and consistency of building blocks, and having a robust supply chain for this one meant fewer compliance headaches. I’ve sat through meetings where the difference between batch success and costly recalls came down to a single, reliable intermediate. Those kinds of real-world stakes color every decision about which bottle gets pulled from the shelf.
Outside the pharma world, innovations in agrochemicals or specialty polymers draw on this compound’s unique pattern of substitution. Agricultural scientists searching for new actives that break resistance cycles often start with halogenated anilines. The nitro and fluoro placements guide metabolic profiles, shaping environmental persistence and effectiveness in the field. A few years back, I watched colleagues screen dozens of aromatic intermediates before landing on this one, drawn by both its clean spectrum and the way it could slot into known reaction pathways without drama. Good science doesn’t stand still, and neither do the ways this molecule gets deployed in new product discovery and testing.
Reliable supply chains build trust, particularly in industries where product failures mean far more than wasted money—they can reset entire R&D timelines. In my own work, I’ve handled intermediates from multiple global sourcing partners, and the better-run operations know how to hold tight tolerances on purity for 2-Nitro-3-Fluoro-4-Bromoaniline. Transparency, regular analysis, and open communication about specifications drive confidence for whole product teams. Quality audits often focus as much on critical building blocks as on finished goods. In these reviews, strong documentation and control over the synthesis and QA process for this molecule pass muster with both industry clients and regulatory inspectors.
Inconsistent or low-quality intermediates invite a mess—impurities creep in, batch yields wobble, and analytical work stretches longer. Having seen the direct impact on timelines (and group morale), I put real value on intermediates that perform as advertised and welcome tough scrutiny. It’s not just a feel-good notion; it's a necessity in serious R&D and manufacturing settings. A dependable sample of 2-Nitro-3-Fluoro-4-Bromoaniline inspires focus on bigger, more meaningful research problems, rather than troubleshooting the basics.
At first glance, the chemical supply marketplace brims with aniline derivatives sporting halogens or nitro groups, but only a handful deliver genuine multifunctional versatility. Some anilines show up with a single nitro group, others bring one or two halogens. 2-Nitro-3-Fluoro-4-Bromoaniline brings them all, arranged just so—not by accident, but as a result of deliberate synthetic planning. I’ve worked with many close relatives of this compound, and none seem to balance synthetic accessibility, downstream utility, and stability quite in the same way.
Single-halogen anilines join simple reactions easily enough, but soon run up against walls during advanced couplings or transformations. Nitroanilines alone don’t tolerate some high-temperature cross-couplings as well, and they often complicate purification. The very presence of a fluoro group on the ring alters electronic character, and over long series of trials, we found it made the difference in getting products that held up to stability testing. Brominated analogs, in some hands, threaten to introduce corrosive byproducts or instability during storage, yet the placement and synthesis history of this molecule keeps those risks low. Having surveyed a wide stretch of what’s available, it feels clear that for high-stakes synthesis with later-stage diversification, the unique blend seen in 2-Nitro-3-Fluoro-4-Bromoaniline fits a rare sweet spot.
Success in modern chemistry often comes down to removing friction—between stages in a synthesis, between the bench and process scale, and between regulatory compliance and innovation. In practice, I’ve seen that friction melt away when intermediates like 2-Nitro-3-Fluoro-4-Bromoaniline perform to high expectations. For chemists facing bottlenecks in yield, cleanliness, or downstream modification, introducing this intermediate often clears the way. It unlocks routes to more diverse compounds, sometimes moving past what was previously considered a hard stop in the literature. Chemical innovation doesn’t always require reinventing the wheel; sometimes, it’s about finding the right part for the job at hand.
Yet, we all know that no single solution works forever. The next wave of chemical supply innovation won’t arrive just by repeating old routines. There’s real room for growth in green synthesis, alternative feedstocks, and further safety documentation for compounds like this—a conversation that’s growing as companies face environmental and social pressures. In group meetings and conferences, I’ve watched industry veterans and rising researchers alike sketch out ideas for solvent reductions, streamlined purifications, and deeper traceability. Bringing these ideas to products like 2-Nitro-3-Fluoro-4-Bromoaniline starts with honest demand from end users, feedback to suppliers, and the discipline to challenge old habits when they slow us down.
I’ve learned through my own missteps that “good enough” kills momentum in the long run. Every new generation of intermediates must measure up, not just in purity and cost but in total life-cycle impact. I see the future of compounds like this shaped by more open sharing of synthetic details, improved cradle-to-grave environmental profiles, and early collaboration between scientists, manufacturers, and even regulatory voices. With the right feedback loops, solutions for cleaner and safer production become the new standard, and 2-Nitro-3-Fluoro-4-Bromoaniline continues evolving to fit new challenges and unmet needs.
Working close to the real challenges of synthesis and scaling up, it’s easy to lose sight of the difference a single building block can make. Yet in hundreds of projects and as many troubleshooting sessions, I’ve come to value intermediates that hold together under both scrutiny and stress. 2-Nitro-3-Fluoro-4-Bromoaniline isn’t “just another intermediate”—it’s a carefully built answer to questions that matter across pharma, agchem, and materials research. The right set of substituents here connects deep knowledge from the literature with hands-on reliability in the lab and out into the market. This compound has earned its place as a standout, and for anyone chasing challenging targets or streamlining their next big project, it’s well worth a closer consideration.